Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/04 → 10/31/08 |
Funding
- Enzon Inc: $103,953.00
Protocol EZ-2053-001: A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-T Lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary
- Mullett, Timothy (PI)